HCA HCA Healthcare Inc

HCA to Present at May Healthcare Conferences

HCA Holdings, Inc. (NYSE: HCA) will present at the following healthcare conferences in May 2017.

May 17, 2017 at 9:20 a.m. (PST) at the Bank of America Merrill Lynch 2017 Health Care Conference held at Encore at the Wynn in Las Vegas, Nevada.

May 24, 2017 at 9:30 a.m. (EST) at the UBS Global Healthcare Conference held at the Grand Hyatt New York in New York City.

A link to the live audio webcast, where applicable, and copies of any related presentation materials will be made available at the Investor Relations section of the Company’s website, www.hcahealthcare.com.

Dates and times may be subject to change, please check the conference schedule or the Investor Relations section of the Company’s website for the latest information.

All references to “Company” and “HCA” as used throughout this release refer to HCA Holdings, Inc. and its affiliates.

EN
28/04/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on HCA Healthcare Inc

Moody's Ratings assigns P-3 rating to HCA Inc.'s commercial paper prog...

Moody's Ratings (Moody's) today assigned a Prime-3 (P-3) rating to the new backed senior unsecured commercial paper program of HCA Inc. ("HCA"). At the same time, we affirmed HCA's existing ratings including the Baa3 ratings of senior unsecured debentures/notes, backed senior unsecured notes and the...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

Expecting a Test of All-Time Highs The market remains relentlessly strong, shrugging off the latest "bearish" headline regarding Moody's U.S. debt downgrade on Friday. This is exactly what we would expect to happen in a bull market, particularly during this "lockout rally," and helps confirm our bullish outlook. To recap, we have been short-term bullish since our 4/22/25 Compass -- when the SPX was testing 5100-5120 support -- but we upgraded our intermediate-term outlook to bullish as well, as...

HCA Healthcare Inc: 1 director

A director at HCA Healthcare Inc sold 15,698 shares at 369.325USD and the significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cle...

Moody's Ratings affirms HCA Inc.'s Baa3 ratings; revises outlook to po...

Moody's Ratings (Moody's) affirmed the ratings of HCA Inc. ("HCA") including the Baa3 ratings of senior unsecured debentures/notes, backed senior unsecured notes and the senior unsecured bank credit facility. At the same time, we revised the outlook to positive from stable. The revision of outlook...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch